New Cholesterol Pill Offers Hope | New Orleans News
About this episode
The episode discusses the FDA's approval of Lipfendra, a new cholesterol-lowering pill that offers an alternative to injectables.
Louisiana’s facing a cholesterol crisis—but there’s a breakthrough: the FDA just approved Lipfendra, the first oral PCSK9 inhibitor, slashing LDL by nearly 60%. Unlike statins, it works differently, offering a powerful, pill-based alternative to injectables. Doctors are thrilled—it could prevent strokes, dementia, and heart attacks. While insurance coverage may take time, talk to your doctor and explore discounts to get this game-changing treatment. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/e77739e6bdfe3688
Topics covered
- cholesterol
- health
- FDA approval
- medical breakthrough
- treatment options
Keywords
- cholesterol
- Lipfendra
- FDA
- PCSK9 inhibitor
- LDL
- healthcare
- treatment
Sponsors
Soli Pillow
Mentioned in this episode
Organizations: FDA
Products: Lipfendra
Places: Louisiana, New Orleans
More episodes of New Orleans News Today | 2 Min News | The Daily News Now!
- Black Land Ownership and Its Legacy | New Orleans News
- Family Finds Themselves in Airbnb Photo | New Orleans News
- Louisiana Families Win $200 Back-to-School Gift Cards | New Orleans News
- Jerk House Under Siege Again | New Orleans News
- Bertha Tests New Orleans Drainage Prep | New Orleans News
- Nolan Wells: A Call for Justice | New Orleans News
Explore listener stats, chart rankings, contacts and more on the New Orleans News Today | 2 Min News | The Daily News Now! podcast page.